Main content area

Immunogenicity of porcine circovirus type 2 nucleic acid vaccine containing CpG motif for mice

Li, Jun, Yu, Jiang, Xu, Shaojian, Shi, Jianli, Xu, Shengnan, Wu, Xiaoyan, Fu, Fang, Peng, Zhe, Zhang, Lingling, Zheng, Shuxuan, Yuan, Xiaoyuan, Cong, Xiaoyan, Sun, Wenbo, Cheng, Kaihui, Du, Yijun, Wu, Jiaqiang, Wang, Jinbao
Virology journal 2016 v.13 no.1 pp. 185
Porcine circovirus-2, antibodies, average daily gain, blood, females, immunity, mice, recombinant vaccines, viremia, virulent strains
BACKGROUND: This study aimed at reseaching the immune effect of porcine circovirus type 2 (PCV2) DNA vaccine containing CpG motif on mice. METHODS: A total of 40 6-week-old female BALB/c mice were randomly divided into four groups which were immunized by 18CpG-pVAX1-ORF2, pVAX1-ORF2, pVAX1 and PBS, respectively, and immunized again 2 weeks later. All mice were challenged with 0.2 mL PCV2 cells virulent strain SD (10⁶.⁰ TCID₅₀/mL) after 4 weeks. Average daily gain, blood antibody levels, microscopic changes and viremia were detected to estimate the effect of DNA vaccine. RESULTS AND DISCUSSION: The results showed that compared to those of the control mice, groups immunized with pVAX1-ORF2 and 18CpG-pVAX1-ORF2 could induce PCV2-specific antibodies. The PCV2-specific antibodies level of 18 CpG-pVAX1-ORF2 groups was higher significantly than other groups and decreased slowly along with time. There was no distinct pathological damage and viremia occurring in mice that inoculated with CpG motif DNA vaccines. The results demonstrated that the DNA vaccine containing 18 CpG could build up resistibility immunity and reduce immune organ damage on mice.